Loading...

Ascendis Pharma A/S

ASND•NASDAQ
HealthcareBiotechnology
$173.06
$-4.49(-2.53%)

Ascendis Pharma A/S (ASND) AI-Powered Stock Analysis

See how Ascendis Pharma A/S scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.

Model Information

The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Ascendis Pharma A/S (ASND) Stock Overall Grade

Ascendis Pharma A/S’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.

B+

Good

Grade Breakdown by Metric

See how each financial and market factor contributes to Ascendis Pharma A/S's overall stock rating.

Forecast

A+

Score

100/100

Financial Growth

A

Score

80/100

Fundamental Growth

B

Score

69/100

Key Ratios

B+

Score

70/100

Sector Comparison

B+

Score

75/100

Industry Comparison

B+

Score

75/100

S&P 500 Benchmark

A

Score

85/100

Analyst Consensus

B+

Score

75/100

Component Analysis Explained

Understand the key factors behind each Ascendis Pharma A/S stock grade, including financials, comparisons, and forecasts.

Frequently Asked Questions